Videos

Featured

View from the Thoraxcenter: ESC Congress 25 Preview

Joost Daemen, Nicolas M Van Mieghem

Watch time: 36m 33s
ESC 25: TRISCEND II Trial: TTVR Outcomes by Baseline TR Severity

Philipp Lurz

Watch time: 4m 15s
TTE and TEE in the New TAVR Era with Dr Victoria Delgado

Victoria Delgado

Watch time: 16m 27s
NY Valves 25: The Tri-QOL Study

Watch time: 5m 58s
EuroPCR 25: The TRICURE EU Study

Julien Dreyfus

Watch time: 4m 9s
SCAI 25: Insights from the TRITAVI Registry

Francesco Pelliccia

Watch time: 11m 23s
NY Valves 25: Lifetime Management in TAVR Patients

Tanush Gupta

Watch time: 12m 2s
TCT Middle East 25: Minimally Invasive Surgery

Rania Hammami, Uthman Aluthman

Watch time: 5m 1s
EuroPCR 25: BIOADAPTOR RCT 3Y Outcomes

Shigeru Saito

Watch time: 2m 29s
EHRA 25: The SwissTAVI Registry

Watch time: 3m 9s

Broadcast

Intervention
Transcatheter Interventions Online 2025 - Day One

Nicolas M Van Mieghem, David Hildick-Smith, Roxana Mehran, et al

PART 1: Dual vs Triple Anti-thrombotic Therapy for Post-PCI Patients with Atrial Fibrillaiton

Jan Steffel, Jur ten Berg, Stefan H Hohnloser, et al

Watch time: 16m 18s
ACC 2021 Discussion: The ISCHEMIA Trial

Gregg Stone, Harriette Van Spall

Watch time: 15m 2s
EuroPCR 2021: Findings From the POEM Study

Giulio G Stefanini

Watch time: 8m 8s
EuroPCR 21: Findings from the 2V-TAVR Study

Uri Landes

Watch time: 7m 3s
AutocathFFR System Outcomes Comparable to Wire-Based FFR

Hector M Garcia-Garcia

Watch time: 6m 24s
EuroPCR 22: MASTER-DAPT Sub-Analysis Shows Consistent Results in Complex PCI Patients

Marco Valgimigli

Watch time: 5m 56s
EuroPCR 22: SCB with Micro-Reservoir Technology in Coronary Lesions

Praveen Chandra

Watch time: 2m 15s
APSC CathLab Workshop: Left Main Bifurcation

Jack Tan Wei Chieh, Goran Stankovic, Nick Cruz, et al

Watch time: 2h 2m 34s
ESC 22 Late-breaker Discussion: The REVIVED Trial

Divaka Perera, Harriette Van Spall

Watch time: 14m 31s
TCT 22: FLASH Trial: US Outcomes of the FlowTriever for PE

Catalin Toma

Watch time: 4m 10s
VEITHsymposium 22: Paclitaxel Mortality Signals

Peter A Schneider, Eric Secemsky, , et al

Watch time: 24m 27s
ACC.23 Late-Breaker Discussion: The BIOVASC Trial

Harriette Van Spall, Roberto Diletti

Watch time: 12m 7s
TCT 23: Four-Year Outcomes from the EVOLUT Low Risk Trial

Michael J Reardon

Watch time: 8m 46s
AI-based OCT Analysis from the BIOMAG-I FIH trial

Hector M Garcia-Garcia

Watch time: 8m 28s
View from the Thoraxcenter: ESC 24 Hot Line Science Wrap Up

Nicolas M Van Mieghem, Joost Daemen

Watch time: 47m 31s
TCT 24 Late-breaking Science Wrap Up

Joost Daemen, Nicolas M Van Mieghem

Watch time: 48m 41s